$LPRO
Open Lending Corp

2024 Q4 Form 10-Q Financial Statement

#000180620124000145 Filed on November 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $23.48M
YoY Change -9.73%
Cost Of Revenue $6.127M
YoY Change 14.12%
Gross Profit $17.35M
YoY Change -15.93%
Gross Profit Margin 73.9%
Selling, General & Admin $14.49M
YoY Change 0.74%
% of Gross Profit 83.53%
Research & Development $992.0K
YoY Change -42.22%
% of Gross Profit 5.72%
Depreciation & Amortization $494.0K
YoY Change 64.67%
% of Gross Profit 2.85%
Operating Expenses $15.48M
YoY Change -3.84%
Operating Profit $1.866M
YoY Change -58.86%
Interest Expense $259.0K
YoY Change -90.75%
% of Operating Profit 13.88%
Other Income/Expense, Net $0.00
YoY Change -100.0%
Pretax Income $2.125M
YoY Change -53.14%
Income Tax $700.0K
% Of Pretax Income 32.94%
Net Earnings $1.437M
YoY Change -52.15%
Net Earnings / Revenue 6.12%
Basic Earnings Per Share $0.01
Diluted Earnings Per Share $0.01
COMMON SHARES
Basic Shares Outstanding 119.4M shares 119.3M shares
Diluted Shares Outstanding 119.5M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $250.2M
YoY Change 7.58%
Cash & Equivalents $250.2M
Short-Term Investments
Other Short-Term Assets $3.364M
YoY Change 7.24%
Inventory
Prepaid Expenses
Receivables $4.566M
Other Receivables $8.041M
Total Short-Term Assets $294.7M
YoY Change 0.3%
LONG-TERM ASSETS
Property, Plant & Equipment $5.534M
YoY Change 49.04%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.662M
YoY Change -33.89%
Total Long-Term Assets $101.0M
YoY Change 12.8%
TOTAL ASSETS
Total Short-Term Assets $294.7M
Total Long-Term Assets $101.0M
Total Assets $395.7M
YoY Change 3.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $282.0K
YoY Change 27.6%
Accrued Expenses $10.30M
YoY Change 10.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $7.500M
YoY Change 100.0%
Total Short-Term Liabilities $31.28M
YoY Change 56.61%
LONG-TERM LIABILITIES
Long-Term Debt $134.0M
YoY Change -5.06%
Other Long-Term Liabilities $6.499M
YoY Change 65.54%
Total Long-Term Liabilities $140.5M
YoY Change -3.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.28M
Total Long-Term Liabilities $140.5M
Total Liabilities $175.2M
YoY Change 3.91%
SHAREHOLDERS EQUITY
Retained Earnings -$184.3M
YoY Change -2.43%
Common Stock $1.282M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $220.5M
YoY Change
Total Liabilities & Shareholders Equity $395.7M
YoY Change 3.22%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $1.437M
YoY Change -52.15%
Depreciation, Depletion And Amortization $494.0K
YoY Change 64.67%
Cash From Operating Activities $11.38M
YoY Change -43.96%
INVESTING ACTIVITIES
Capital Expenditures $110.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$900.0K
YoY Change 28.57%
Cash From Investing Activities -$1.010M
YoY Change 26.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.885M
YoY Change -82.71%
NET CHANGE
Cash From Operating Activities 11.38M
Cash From Investing Activities -1.010M
Cash From Financing Activities -1.885M
Net Change In Cash 8.482M
YoY Change -1.37%
FREE CASH FLOW
Cash From Operating Activities $11.38M
Capital Expenditures $110.0K
Free Cash Flow $11.27M
YoY Change -44.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001806201
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
OPEN LENDING CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-5031428
dei Entity Address Address Line1
EntityAddressAddressLine1
1501 S. MoPac Expressway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 450
dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78746
dei City Area Code
CityAreaCode
512
dei Local Phone Number
LocalPhoneNumber
892-0400
dei Trading Symbol
TradingSymbol
LPRO
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
375000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10303000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8131000 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
7500000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
4688000 usd
CY2024Q3 lpro Liability For Claims And Claims Adjustment Expense Current
LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent
10750000 usd
CY2023Q4 lpro Liability For Claims And Claims Adjustment Expense Current
LiabilityForClaimsAndClaimsAdjustmentExpenseCurrent
6464000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2445000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
932000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
31280000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20590000 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
134002000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
139357000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3463000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3450000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6499000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5060000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
168457000 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
128198185 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
118819795 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
80948000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
102521000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3601000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4075000 usd
us-gaap Operating Expenses
OperatingExpenses
50179000 usd
us-gaap Operating Expenses
OperatingExpenses
48252000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
13179000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13989000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
36819000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4563000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9907000 usd
us-gaap Net Income Loss
NetIncomeLoss
9426000 usd
us-gaap Net Income Loss
NetIncomeLoss
26912000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119128801 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121318872 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119427952 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
122065718 shares
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
119350001 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
250233000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
240206000 usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
10714000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
6463000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4566000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4616000 usd
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
17810000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
28704000 usd
CY2024Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
8041000 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
7035000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
3364000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2852000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3990000 usd
CY2024Q3 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
22098000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
610000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
65614000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
70113000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3662000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5535000 usd
CY2024Q3 us-gaap Assets
Assets
395707000 usd
CY2023Q4 us-gaap Assets
Assets
374037000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
282000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
175244000 usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17590000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16917000 usd
us-gaap Gross Profit
GrossProfit
63358000 usd
us-gaap Gross Profit
GrossProfit
85604000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33318000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13260000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13136000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
37352000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
9278000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
7317000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
238411000 usd
dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2024Q3 us-gaap Assets Current
AssetsCurrent
294728000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
289876000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5534000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3913000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4071000 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
128198185 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119255709 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1282000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
502032000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-184323000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-193749000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
395707000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
374037000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1282000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
501918000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
8942476 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
9378390 shares
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
98414000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
103985000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
220463000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
205580000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23476000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26006000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6127000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5369000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
17349000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
20637000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9594000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9875000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31041000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4897000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4509000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
992000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1717000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
15483000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
16101000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1866000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4536000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2962000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
8468000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
7841000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3221000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2801000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2125000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4535000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
688000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1532000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1437000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3003000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119252503 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119480577 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121298880 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
205580000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1892000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1021000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
5087000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
211538000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2459000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-116000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
2902000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
216783000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12538000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
205549000 usd
dei Document Type
DocumentType
10-Q
dei Entity File Number
EntityFileNumber
001-39326
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2799000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120217857 shares
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2253000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-10000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1437000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
220463000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
212824000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1844000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-129000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
21528000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2361000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-131000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
11371000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
219150000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2684000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-5000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10107000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3003000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
214725000 usd
us-gaap Net Income Loss
NetIncomeLoss
9426000 usd
us-gaap Net Income Loss
NetIncomeLoss
26912000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6408000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6826000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1281000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
824000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
321000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
319000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
511000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
461000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4499000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
386000 usd
us-gaap Proceeds From Other Operating Activities
ProceedsFromOtherOperatingActivities
37000 usd
us-gaap Proceeds From Other Operating Activities
ProceedsFromOtherOperatingActivities
10000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-50000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-455000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
10594000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-26199000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
576000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
789000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-92000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-67000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2164000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2299000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
881000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
513000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-464000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-412000 usd
us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
4286000 usd
us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
1749000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2838000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
218000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20976000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
65903000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
161000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
103000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2577000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1485000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2738000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1588000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2813000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2813000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
31322000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1147000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
288000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3960000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34423000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14278000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
29892000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
246669000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
208519000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
260947000 usd
us-gaap Interest Paid Net
InterestPaidNet
7981000 usd
us-gaap Interest Paid Net
InterestPaidNet
7593000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-817000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9008000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
592000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2000 usd
lpro Share Based Compensation For Capitalized Software Development
ShareBasedCompensationForCapitalizedSoftwareDevelopment
196000 usd
lpro Share Based Compensation For Capitalized Software Development
ShareBasedCompensationForCapitalizedSoftwareDevelopment
63000 usd
lpro Capitalized Software Development Costs Accrued But Not Paid
CapitalizedSoftwareDevelopmentCostsAccruedButNotPaid
244000 usd
lpro Capitalized Software Development Costs Accrued But Not Paid
CapitalizedSoftwareDevelopmentCostsAccruedButNotPaid
230000 usd
lpro Accrued Excise Tax From Share Repurchases
AccruedExciseTaxFromShareRepurchases
0 usd
lpro Accrued Excise Tax From Share Repurchases
AccruedExciseTaxFromShareRepurchases
290000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP have been omitted from these unaudited condensed consolidated financial statements, as permitted by Securities and Exchange Commission (“SEC”) rules and regulations. The Company believes the disclosures made in these unaudited condensed consolidated financial statements are adequate to make the information herein not misleading.
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentrations of revenue and credit risks <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s largest insurance carrier partner accounted for 35% of the Company’s total revenue during the three and nine months ended September 30, 2024. The Company’s largest insurance carrier partners accounted for 29% and 10% of the Company's total revenue during the three months ended September 30, 2023 and 32% and 11% during the nine months ended September 30, 2023. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, restricted cash, accounts receivable and contract assets to the extent of the amounts recorded on the balance sheets.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are deposited in commercial analysis accounts, money market funds and U.S. Treasury securities at financial institutions with high credit standing. Restricted cash relates to funds held by the Company on behalf of the insurance partners, designated for the use of insurance claim payments. Restricted cash is deposited in commercial analysis accounts at one financial institution. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurance limits of $250,000 per institution. The Company has not experienced any losses on its deposits of cash and cash equivalents and management believes the Company is not exposed to significant risks on such accounts.</span></div>The Company’s accounts receivable and contract assets are derived from revenue earned from customers. The Company maintains an allowance for expected credit losses, which represents an estimate based primarily on market implied lifetime probabilities of default and loss severities for assets with similar risk characteristics. As these inputs are derived from market observations, they inherently include forward-looking expectations about macro-economic conditions. The allowance is evaluated quarterly by the Company for adequacy by taking into consideration factors such as reasonableness of the market implied loss statistics, historical lifetime loss data and credit quality of the customer base. Provisions for the allowance for expected credit losses attributable to bad debt are recorded as general and administrative expenses. Account balances deemed uncollectible are written off, net of actual recoveries. If circumstances related to specific customers change, the Company’s estimate of the recoverability of its contract assets could be further adjusted. The Company does not have any material accounts receivable or contract assets receivable balances that are past due and has not written off any balances in its portfolio for the periods presented.
CY2023Q4 lpro Accounts And Contract Asset Receivable Allowance For Credit Loss
AccountsAndContractAssetReceivableAllowanceForCreditLoss
100000 usd
CY2024Q3 lpro Accounts And Contract Asset Receivable Allowance For Credit Loss
AccountsAndContractAssetReceivableAllowanceForCreditLoss
100000 usd
us-gaap Use Of Estimates
UseOfEstimates
Use of estimates and judgments<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates, and those differences may be material. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to estimates are recognized prospectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant items subject to such estimates and assumptions include, but are not limited to, profit share revenue recognition and the corresponding impact on contract assets and assessing the realizability of deferred tax assets. The Company bases its estimates on historical trends and relevant assumptions that it believes to be reasonable under the circumstances. Accordingly, actual results could be materially different from those estimates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with profit share revenue recognition and the estimation of contract assets, the Company uses a forecast model to estimate variable consideration based on undiscounted expected future profit share to be received from the insurance partners. The forecast model projects loan-level earned premiums and insurance claim payments driven by projections of prepayment rate, loan default rate and severity of loss. These assumptions are derived from an analysis of the historical performance of the active loan portfolio, prevailing default and prepayment trends, and macroeconomic projections. Estimates of variable consideration generated by the forecast model are constrained to the extent that it is probable that a significant reversal of revenue will not occur in future periods.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually assesses the default and prepayment assumptions of the forecast model against reported performance and lender delinquency data. The forecast model is updated to consider the actual prepayment rate, default, and severity experience with macroeconomic conditions.</span></div>
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
29314000 usd
lpro Contract With Customer Asset Additions
ContractWithCustomerAssetAdditions
95783000 usd
us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-14764000 usd
lpro Contract With Customer Asset Reclassified To Receivable Payable
ContractWithCustomerAssetReclassifiedToReceivablePayable
41020000 usd
lpro Contract With Customer Asset Payments Received From Insurance Carriers
ContractWithCustomerAssetPaymentsReceivedFromInsuranceCarriers
29375000 usd
us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
-30000 usd
CY2024Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
39908000 usd
CY2024Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
33731000 usd
CY2024Q3 lpro Contract With Customer Asset Additions
ContractWithCustomerAssetAdditions
30467000 usd
CY2024Q3 us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-6960000 usd
CY2024Q3 lpro Contract With Customer Asset Reclassified To Receivable Payable
ContractWithCustomerAssetReclassifiedToReceivablePayable
11399000 usd
CY2024Q3 lpro Contract With Customer Asset Payments Received From Insurance Carriers
ContractWithCustomerAssetPaymentsReceivedFromInsuranceCarriers
5917000 usd
CY2024Q3 us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
-14000 usd
CY2024Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
39908000 usd
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
17800000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
28700000 usd
CY2024Q3 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
22100000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
600000 usd
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
998000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1268000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
141502000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
144045000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
7500000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4688000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
134002000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
139357000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1500000 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.324
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.338
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9900000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.326
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.269
CY2024Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
3300000 usd
us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
3800000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1437000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3003000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9426000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
26912000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119252503 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120217857 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119128801 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121318872 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1437000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3003000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
9426000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
26912000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119252503 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120217857 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119128801 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121318872 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
228074 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1081023 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
299151 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
746846 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119480577 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121298880 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119427952 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
122065718 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1979519 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
848367 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1241817 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
848367 shares
CY2024Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
235505000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
211792000 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001806201-24-000145-index-headers.html Edgar Link pending
0001806201-24-000145-index.html Edgar Link pending
0001806201-24-000145.txt Edgar Link pending
0001806201-24-000145-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lpro-20240930.htm Edgar Link pending
lpro-20240930.xsd Edgar Link pending
lpro-20240930ex311.htm Edgar Link pending
lpro-20240930ex321.htm Edgar Link pending
lpro-20240930_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lpro-20240930_cal.xml Edgar Link unprocessable
lpro-20240930_def.xml Edgar Link unprocessable
lpro-20240930_lab.xml Edgar Link unprocessable
lpro-20240930_pre.xml Edgar Link unprocessable
lpro-20240930_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable